Get started
Author

Masayuki Higuchi

Identification of CRE1 as a cytokinin receptor from Arabidopsis
2001 · Tsutomu Inoue, Masayuki Higuchi, et al. · Nature · 963
Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer
2019 · Yasuhiro Koh, Satomi Yagi, et al. · Clinical Lung Cancer · 47
Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients
2017 · Satomi Yagi, Yasuhiro Koh, et al. · PLoS ONE · 44
PDF
Abstract B27: Longitudinal evaluation of PD-L1 expression on circulating tumor cells (CTCs) in non-small cell lung cancer (NSCLC) patients treated with nivolumab
2020 · Mio Ikeda, Yasuhiro Koh, et al. · Clinical Cancer Research · 37
Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab
2021 · Mio Ikeda, Yasuhiro Koh, et al. · Cancers · 31
PDF
Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma
2021 · Kazuto Takahashi, Kazuya Ofuji, et al. · Cancer Medicine · 20
Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system
2020 · Mio Ikeda, Yasuhiro Koh, et al. · Cancer Medicine · 18
PDF
Predictive impact of PD-L1-expressing circulating tumor cells in NSCLC patients treated with nivolumab.
2017 · Ryota Shibaki, Yasuhiro Koh, et al. · Journal of Clinical Oncology · 2
Abstract A032: Clinical significance of vimentin-positive AXL-expressing circulating tumor cells in advanced non-small-cell lung cancer patients
2019 · Mio Ikeda, Yasuhiro Koh, et al. · Molecular Cancer Therapeutics · 1
Abstract 775: Longitudinal investigation of PD-L1 expression on circulating tumor cells (CTCs) in non-small cell lung cancer (NSCLC) patients treated with nivolumab
2020 · Yasuhiro Koh, Mio Ikeda, et al. · Cancer Research
Abstract 414: Detection of AXL-expressing circulating tumor cells (CTCs) in non-small-cell lung cancer (NSCLC) patients using an automated microcavity array (MCA) system
2019 · Mio Ikeda, Yasuhiro Koh, et al. · Clinical Research (Excluding Clinical Trials)
Abstract 414: Detection of AXL-expressing circulating tumor cells (CTCs) in non-small-cell lung cancer (NSCLC) patients using an automated microcavity array (MCA) system
2019 · Mio Ikeda, Yasuhiro Koh, et al. · Cancer Research
Abstract 5595: Predictive impact of sequential evaluation of PD-L1-expressing circulating tumor cells in NSCLC patients treated with nivolumab
2018 · Yasuhiro Koh, Hiroaki Akamatsu, et al. · Cancer Research
Abstract A056: Sequential tracking of PD-L1 expression on circulating tumor cells in NSCLC patients treated with nivolumab
2018 · Hiroaki Akamatsu, Yasuhiro Koh, et al. · Molecular Cancer Therapeutics
Abstract 3778: PD-L1 expression on circulating tumor cells and its comparison with tumor tissues in Japanese lung cancer patients
2017 · Hiroaki Akamatsu, Yasuhiro Koh, et al. · Cancer Research
P2.01-060 Comparative Analysis of PD-L1 Expression between Circulating Tumor Cells and Tumor Tissues in Patients with Lung Cancer
2017 · Yasuhiro Koh, Satomi Yagi, et al. · Journal of Thoracic Oncology
PDF
Abstract 2257: Differential expression of PD-L1 on circulating tumor cells among patients with advanced lung cancer
2016 · Woong Kim, Yasuhiro Koh, et al. · Cancer Research
Abstract 2244: Development of an automated device for size-based enrichment and isolation of circulating tumor cells in lung cancer patients
2016 · Satomi Yagi, Yasuhiro Koh, et al. · Cancer Research
Patterns of PD-L1 expression on circulating tumor cells in Japanese patients with advanced lung cancer.
2016 · Yasuhiro Koh, Hiroaki Akamatsu, et al. · Journal of Clinical Oncology
Abstract B138: Evaluation of a novel automated device for size-based enrichment and isolation of CTCs in patients with advanced lung cancer
2015 · Woong Kim, Yasuhiro Koh, et al. · Molecular Cancer Therapeutics
Works count: 20
Citation count: 1,163
H-index: 7
I10-index: 7
Year
Topic
Type